Business Wire

Marquee Brands Broadens Global Portfolio with Strategic Acquisition of Stance

19.11.2025 21:00:00 CET | Business Wire | Press Release

Share

Marquee Brands, the premier global brand accelerator, today announced the acquisition of Stance, the innovative lifestyle and performance sock brand. Founded in 2009 in San Clemente, California, Stance joins Marquee Brands’ renowned portfolio, home to some of the world’s most notable brands, including Martha Stewart, Laura Ashley, Sur La Table, BCBG, Ben Sherman, Body Glove and Dakine. The addition of Stance brings total retail sales across Marquee’s portfolio to $4.5 Billion USD.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251119216623/en/

Marquee also announces a new partnership with United Legwear and Apparel Co. (ULAC), which becomes the brand’s core global licensee, managing operations across all territories apart from China. With products sold in 42 countries through more than 1,100 U.S. wholesale accounts, e-commerce, international distributors and mono-branded retail stores, ULAC will oversee Stance’s core product segments of socks and underwear across Men’s, Women’s and Children’s. In this role, ULAC will lead product design, development, retail and ecommerce operations and distribution.

“We are thrilled to welcome Stance into the portfolio as an established cultural touchpoint known for bold design, creativity and collaborations with athletes, musicians and artists,” said Heath Golden, CEO of Marquee Brands. “We are incredibly excited to build on that momentum in partnership with United Legwear, an industry and category leader. Together we see an opportunity to build global scale, accelerate category expansion and advance our shared strategy of investing in high-equity brands with enduring consumer relevance.”

Recognized for redefining the sock category, Stance has built a loyal following through its premium quality, material innovation and exceptional design. Now part of Marquee Brands, the acquisition establishes the company’s foothold in the everyday essentials space and extends its reach across the lifestyle category. Stance’s collection lineup includes longstanding partnerships with the NBA, MLB, Disney, Marvel, Star Wars and Warner Bros. Discovery, and prior collaborations with leading artists, athletes and cultural figures, including Billie Eilish, Dwyane Wade and the Estate of Basquiat. Established in fabric technology and development, Stance is well-positioned to broaden its product range, starting with activewear, athleisure and footwear.

“ULAC partners on brands that share our drive to innovate and inspire,” said Isaac E. Ash, CEO & President of United Legwear & Apparel Co. (ULAC). “Stance is a perfect fit – a pioneering brand that transformed everyday essentials into expressions of style, and has built an impressive following through bold design, cultural storytelling and a community of athletes and artists. ULAC is excited to partner with Marquee Brands and continue that legacy.”

Marquee Brands, backed by longstanding financial sponsor Neuberger Berman, continues to scale its platform by investing in globally recognized brands with consumer relevance and applying a proven business model that drives operational excellence, key category expansion and long-term value creation across markets.

RBC Capital Markets served as financial advisor and Greenberg Traurig acted as legal advisor to Marquee Brands. Solomon Partners served as financial advisor and Jones Day acted as legal advisor to Stance.

ABOUT MARQUEE BRANDS

Marquee Brands is the premier accelerator of timeless brands, unlocking value and building global influence. With a focus on driving growth and building sustainable brand equity, we partner with best-in-class manufacturers, operators, retailers, and distributors to scale brands across markets and channels. Marquee Brands’ global portfolio spans three distinct platforms: Home & Culinary, Fashion & Lifestyle, Expressive Luxury and Active & Outdoor. The portfolio of brands includes Martha Stewart, Laura Ashley, Sur La Table, Emeril Lagasse, America’s Test Kitchen, BCBGMAXAZRIA, BCBG, Ben Sherman, Bruno Magli, Anti Social Social Club, Totes, Isotoner, Destination Maternity, Motherhood, A Pea in the Pod, Stance, Dakine and Body Glove. For more information visit, www.marqueebrands.com.

ABOUT UNITED LEGWEAR & APPAREL CO. (ULAC)

ULAC (ULAC.com) is a New York–based global designer and distributor of apparel, legwear, bodywear, and accessories. Founded by Isaac E. Ash in 1998, ULAC holds distribution partnerships with Scotch & Soda, Hurley, and Ted Baker. The company is also a licensee for leading brands including PUMA, Skechers, Van Heusen, DKNY, Levi’s, Champion, Prince, Arrow, and Weatherproof, owns the Pro Player and Lemon brands and develops private-label programs for major retailers worldwide.

Guided by a commitment to quality, value, and innovation, ULAC delivers best-in-class products from design table to delivery dock, operating with integrity, excellence, and a forward-thinking approach that meets the needs of global consumers.

ABOUT STANCE

Founded in 2009, Stance is a leading lifestyle brand that redefined the sock and apparel industry through creativity, self-expression and premium design. Known for its bold aesthetics, innovative materials and high-quality craftsmanship, Stance has transformed everyday essentials into a canvas for individuality. From performance gear to casual basics, Stance partners with world-class athletes, artists and cultural icons to celebrate originality and inspire confidence in every step. Stance products are sold globally in specialty retailers, major department stores and online at www.stance.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251119216623/en/

Contacts

Corporate@marqueebrands.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye